Natural products as potential drug permeation enhancer in transdermal drug delivery system

Archives of Dermatological Research

Volumn 306, Issue 5, 2014, Pages 419-426

  Patil, Umesh K ^a   Saraogi, Richa ^b  

^a Dr Harisingh Gaur University   (India)

^b SR Group of Institution   (India)

Author keywords

Fatty acids; Herbal extracts; QSAR; SAR; Skin penetration enhancers; Stratum corneum; Terpenes

Indexed keywords

2 PYRROLIDONE DERIVATIVE; ALCOHOL DERIVATIVE; ALPHA TERPINOL; CAFFEINE; CARVONE; CINEOLE; DICLOFENAC; ESSENTIAL OIL; FATTY ACID; FATTY ACID ESTER; FLUOROURACIL; GLYCOL; HALOPERIDOL; KETOPROFEN; KETOTIFEN; LAUROCAPRAM; LIMONENE; MEFENAMIC ACID; MENTHOL; NATURAL PRODUCT; NEROLIDOL; OXAZOLIDINONE DERIVATIVE; PENETRATION ENHANCING AGENT; POLYMER; SULFOXIDE; SURFACTANT; TERPENE; TERPENE DERIVATIVE; UNCLASSIFIED DRUG; UREA; WATER; BIOLOGICAL PRODUCT; PLANT MEDICINAL PRODUCT;

BIOAVAILABILITY; POLYMERIZATION; PRIORITY JOURNAL; REVIEW; SKIN IRRITATION; STRATUM CORNEUM; TRANSDERMAL DRUG ADMINISTRATION; DRUG DELIVERY SYSTEM; DRUG EFFECTS; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MEDICINAL CHEMISTRY; PERMEABILITY; PROCEDURES; SKIN; SKIN ABSORPTION;

ADMINISTRATION, CUTANEOUS; BIOLOGICAL PRODUCTS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; HUMANS; PERMEABILITY; PLANT PREPARATIONS; SKIN; SKIN ABSORPTION; SKIN PHYSIOLOGICAL PHENOMENA;

EID: 84903773937     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-014-1445-y     Document Type: Review

References (77)

1. Akimoto T, Aoyagi T, Minoshima J, Nagase Y (1997) Polymeric percutaneous drug penetration enhancer-synthesis and enhancing property of PEG/PDMS block copolymer with a cationic end group. J Control Release 49(13):229-241 (Pubitemid 28020276)
2. Akimoto T, Kawahara K, Nagase Y, Aoyagi T (2001) Polymeric transdermal drug penetration enhancer: the enhancing effect of oligodimethylsiloxane containing a glucopyranosyl end group. J Control Release 77(1-2):49-57 (Pubitemid 33022615)
3. Amin S, Mir SR, Kohli K, Ali B, Ali M (2010) A study of the chemical composition of black cumin oil and its effect on penetration enhancement from transdermal formulation. Nat Prod Res 24(12):115-1151
4. Aqil M, Ahad A, Sultana Y, Ali A (2007) Status of terpenes as skin permeation enhancers. Drug Discov Today 12:1061-1067 (Pubitemid 350180560)
5. Arellano A, Santoyo S, Martin C, Ygartua P (2006) Enhancing effect of terpenes on the in vitro percutaneous absorption of diclofenac sodium. Int J Pharm 130:141-147
6. Aungst B (1995) Fatty acids as skin permeation enhancers. In: Smith EW, Maibach HI (eds) Percutaneous penetration enhancers. CRC Press, Florida, pp 277-287
7. Aungst BJ, Rogers NJ, Shefter E (1986) Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amines. Int J Pharm 33:225-234 (Pubitemid 17197807)
8. Barry BW (1983) Dermatological formulation: percutaneous absorption, vol 18. Mercel Dekker, New York, pp 225-238
9. Barry BW (1987) Mode of action of penetration enhancers in human skin. J Control Release 6:85-97
10. Barry BW (1991) Lipid-protein-partitioning theory of skin penetration enhancement. J Control Release 15:237-248
11. Barry BW (1991) Modern methods of promoting drug absorption through the skin. Mol Asp Med 12:195-241
12. Barry BW (1991) The LPP theory of skin penetration enhancement. In vitro percutaneous absorption: principles, fundamentals and applications. CRC Press, Florida, pp 165-185
13. Barry BW, Williams AC (1993) Terpenes as skin penetration enhancers. In: Walters KA, Hadgraft J (eds) Pharmaceutical skin penetration enhancement. Marcel Dekker, New York, pp 95-111
14. Ben-Shabat S, Baruch N, Sintov AC (2007) Conjugates of unsaturated fatty acids with propylene glycol as potentially less irritant skin penetration enhancers. Drug Dev Ind Pharm 33:1169-1175 (Pubitemid 350208737)
15. Benson ACH (2005) Transdermal drug delivery: penetration enhancement techniques. Cur Drug Deliv 2:23-33
16. Bhatia KS, Singh J (1998) Synergistic effect of ionto-ability through porcine skin. J Pharm Sci 87:462-469
17. Brain K, Hadgraft J, Al-Shatalebi M (1990) Membrane modification in activity of plant molluscicides. Planta Med 56:663
18. Brown MB, Martin GP, Jones SA, Akomeah FK (2006) Dermal and transdermal drug delivery system: current and future prospects. Drug Deliv 13:175-187
19. Chi SC, Park ES, Kim H (1995) Effect of penetration enhancers on flurbiprofen permeation through rat skin. Int J Pharm 126:267
20. Cho CW, Choi JS, Kim SJ, Shin SC (2009) Enhanced transdermal delivery of loratadine from the EVA matrix. Drug Deliv 16(4):230-235
21. Cho CW, Choi JS, Yang KH, Shin SC (2009) Enhanced transdermal absorption and pharmacokinetic evaluation of pranoprofenethylene-vinyl acetate matrix containing penetration enhancer in rats. Arch Pharm Res 32(5):747-753
22. 2+ channel subtypes in bovine chromaffin cells. J Ethnopharmacol 74:75-81
23. Cole L, Heard C (2007) Skin permeation enhancement potential of Aloe vera and a proposed mechanism of action based upon size exclusion and pull effect. Int J Pharm 333(1-2):10-16 (Pubitemid 46283265)
24. Fang JY, Hwang TL, Fang CL, Chiu HC (2003) In vitro and in vivo evaluations of the efficacy and safety of skin permeation enhancers using flurbiprofen as a model drug. Int J Pharm 255:153-166
25. Francis G, Kerem Z, Makkar HP, Becker K (2002) The biological action of saponins in animal systems: a review. Br J Nutr 88:587-605 (Pubitemid 36082888)
26. Gao S, Singh J (1997) Mechanism of transdermal transport of 5-fluorouracil by terpenes-carvone, 1, 8-cineole and thymol. Int J Pharm 154:67-77 (Pubitemid 27326821)
27. Ghafourian T, Zandasrar P, Hamishekar H, Nokhodchi A (2004) The effect of penetration enhancers on drug delivery through skin: a QSAR study. J Control Release 99:113-125 (Pubitemid 39165738)
28. Godwin DA, Michniak BB (1999) Influence of drug lipophilicity on terpenes as transdermal penetration enhancers. Drug Dev Ind Pharm 25:905-915 (Pubitemid 29350272)
29. Guy RH, Hadgraft J (1987) The effect of penetration enhancers on the kinetics of percutaneous absorption. J Control Release 5:43-51 (Pubitemid 17106645)
30. Guy RH, Hadgraft J (1989) Selection of dug candidates for transdermal drug delivery. In: Walters KA, Hadgraft J (eds) Transdermal drug delivery developmental issues and research initiatives. Marcel Dekker, New York, pp 59-81
31. Hadgraft J (2001) Skin, the final frontier. Int J Pharm 224:1-18
32. Heard CM, Kung D, Thomas CP (2006) Skin penetration enhancement of mefenamic acid by ethanol and 1, 8-cineole can be explained by the 'pull' effect. Int J Pharm 321:167-170 (Pubitemid 44247424)
33. Hostettmann K, Marston A (1995) Chemistry and pharmacology of natural products: Saponins. Cambridge University Press, Cambridge, pp 234-284
34. Hsu LR, Huang YB, Wu PC, Tsai YH (1994) Percutaneous absorption of piroxicam from FAPG base through rat skin: effects of fatty acid added to FAPG base. Int J Pharm 106:1-6
35. Ibrahim SA, Li SK (2010) Efficiency of fatty acids as chemical penetration enhancers: mechanisms and structure enhancement relationship. Pharm Res 27(1):115-125
36. Jain R, Aqil M, Ahad A, Ali S, Khar RK (2008) Basil oil is a promising skin permeation enhancer for transdermal delivery of labetalol hydrochloride. Drug Dev Ind Pharm 34:384-389 (Pubitemid 351519668)
37. Kang L, Yap CW, Lim PFC, Chen YZ, Ho PC, Chan YW, Wong GP, Chan SY (2007) Formulation development of transdermal dosage form: quantitative structure activity relationship model for predicting activity of terpenes that enhance drug penetration through human skin. J Control Release 120:211-219 (Pubitemid 47058642)
38. Kanikkannan N, Babu RJ, Singh M (2006) Structure-activity relationship of chemical penetration enhancers. In: Smith EW, Maibach HI (eds) Percutaneous penetration enhancers, 2nd edn. CRC Press, Florida, pp 17-32
39. Kanikkannan N, Singh M (2002) Skin permeation enhancement effect and skin irritation of saturated fatty alcohols. Int J Pharm 248(1-2):219-228 (Pubitemid 35341424)
40. Kim MJ, Doh HJ, Choi MK, Chung SJ, Shim CK, Kim DD, Kim JS, Yong CS, Choi HG (2008) Skin permeation enhancement of diclofenac by fatty acids. Drug Deliv 15(6):373-379
41. Kimura C, Nakanishi T, Tojo K (2007) Skin permeation of ketotifen applied from stick-type formulation. Eur J Pharm Biopharm 67:420-424 (Pubitemid 47211906)
42. Klang V, Matsko N, Zimmermann NM, Vojnikovic E, Valenta C (2010) Enhancement of stability and skin permeation by sucrose stearate and cyclodextrins in progesterone nanoemulsions. Int J Pharm 393(1-2):153-161
43. Kligman AM (1965) Topical pharmacology and toxicology of dimethylsulfoxide. J Am Med Assoc 193:796-804
44. Komata Y, Inaoka M, Kaneko A, Fujie T (1992) In vitro percutaneous absorption of thiamine disulfide from a mixture of propylene glycol and fatty acid. J Pharm Sci 81:744-746 (Pubitemid 23006809)
45. Kunta JR, Goskonda VR, Brotherton HO, Khan MA, Reddy IK (1997) Effect of menthol and related terpenes on the percutaneous absorption of propranolol across excised hairless mouse skin. J Pharm Sci 86:1369-1373 (Pubitemid 28018316)
46. Melzig MF, Bader G, Loose R (2001) Investigations of the mechanism of membrane activity of selected triterpenoid saponins. Planta Med 67:43-48 (Pubitemid 32199944)
47. Menin L, Panchichkina M, Keriel C, Olivares J, Braun U, Seppert EK, Saks VA (2001) Macro-compartmentation of total creatine in cardiomyocytes revisited. Mol Cell Biochem 220:149-159 (Pubitemid 32519950)
48. Merfort I, Heilmann J, Hagedorn-Leweke U, Lippold BC (1994) In vivo skin permeation studies of chamomile flavones. Pharmazie 49(7):509-511 (Pubitemid 24240336)
49. Moghimipour E, Sajadi Tabassi SA, Ramazani M, Lobenberg R (2002) Enhanced permeability of gentamicin sulfate through shed snake-skin and liposomal membranes by different enhancers. IJBMS 6(1):9-20
50. Mohammadi-Samani S, Jamshidzadeh A, Montaseri H, Rangbar-Zahedani M, Kianrad R (2010) The effects of some permeability enhancers on the percutaneous absorption of lidocaine. Pak J Pharm Sci 23(1):83-86
51. Morimoto K, Tojima H, Haruta T, Suzuki M, Kakemi M (1996) Enhancing effect of unsaturated fatty acids with various structures on the permeation of indomethacin through rat skin. J Pharm Pharmacol 48:1133-1137 (Pubitemid 126449482)
52. Namba T, Sekiya K, Kadota S, Hattori M, Katayama K, Koizumi T (1992) Studies on the baths with crude drug: the effects of Senkyu extract as skin penetration enhancer. Yakugaku Zasshi 112(9):638-644
53. Namba T, Sekiya K, Toshinal A, Kadota S, Hatanaka T, Katayama K, Koizumi T (1995) Study on baths with crude drug. II: the effects of Coptidis rhizoma extracts as skin permeation enhancer. Yakugaku Zasshi 115(8):618-625
54. Nokhodchi A, Nazemiyeh H, Ghafourian T, Hassan-Zahed D, Valizadeh H, Bahary LA (2002) The effect of glycyrrhizin on the release rate and the skin permeation of diclofenac sodium from topical formulations. Farmao 57(11):883-888 (Pubitemid 35341734)
55. Ogiso T, Shintani M (1990) Mechanism for the enhancement effect of fatty acids on the percutaneous absorption of propranolol. J Pharm Sci 79:1065-1071
56. Oh HJ, Oh YK, Kim CK (2001) Effects of vehicles and enhancers on transdermal delivery of melatonin. Int J Pharm 212:63-71
57. Okamoto H, Ohyabu M, Hashida M (1987) Enhanced penetration of mitomycin C through hairless mouse and rat skin by enhancers with terpene moieties. J Pharm Pharmacol 39:531-534 (Pubitemid 17120952)
58. Pfister WR, Hsieh DS (1990) Permeation enhancers compatible with transdermal drug delivery system. Part II: system design considerations. Med Device Technol 1:28-33
59. Plock A, Sokolowska-Kohler W, Presber W (2001) Application of flow cytometry and microscopical methods to characterize the effect of herbal drugs on leishmania spp. Exp Parasitol 97:141-153 (Pubitemid 32980596)
60. Rhee YS, Choi JS, Park ES (2001) Transdermal delivery of ketoprofen using microemulsions. Int J Pharm 228:161-170
61. Sapra B, Jain S, Tiwary AK (2008) Transdermal delivery of carvedilol containing glycyrrhizin and chitosan as permeation enhancers: biochemical, biophysical, microscopic and pharmacodynamic evaluation. Drug Deliv 15(7):443-454
62. Sapra B, Jain S, Tiwary AK (2009) Effect of Asparagus racemosus extract on transdermal delivery of carvedilol: a mechanistic study. Pharm Sci Tech 10(1):199-210
63. Seeman P (1974) Ultra-structure of membrane lesions in immune lysis, osmotic lysis and drug-induced lysis. Fed Proc 33:2116-2124
64. Seeman P, Cheng D, Iles GH (1973) Structure of membrane holes in osmotic and saponin hemolysis. J Cell Biol 56:519-527
65. Southwell D, Barry BW (1983) Penetration enhancers for human skin: mode of action of 2-pyrrolidone and dimethylformamide on partition and diffusion of model compounds water, n-alcohol and caffeine. J Invest Dermatol 80(6):507-514 (Pubitemid 13062264)
66. Thakur RA, Wang Y, Michniak BB (2006) Essential oils and terpenes. In: Smith EW, Maibach HI (eds) Percutaneous penetration enhancers, 2nd edn. CRC Press, Boca Raton, pp 159-173
67. Vaddi HK, Ho PC, Chan SY (2000) Terpenes in propylene glycol as skin penetration enhancers: permeation and partition of haloperidol, Fourier transform infrared spectroscopy, and differential scanning calorimetry. J Pharm Sci 91:1639-1651 (Pubitemid 34680226)
68. Wang Y, Thakur R, Fan Q, Michniak B (2005) Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery. Eur J Pharm Biopharm 60(2):179-191 (Pubitemid 40804560)
69. William AC, Barry BW (2004) Penetration enhancers. Adv Drug Deliv Rev 56:603-618
70. Williams AC, Barry BW (1991) The enhancement index concept applied to terpene penetration enhancer for human skin and model lipophilic (oestradiol) and hydrophilic (5 fluorouracil) drugs. Int J Pharm 74:157-168
71. Woldemichael GM, Wink M (2001) Identification and biological activities of triterpenoid saponins from Chenopodium quinoa. J Agric Food Chem 49:2327-2332 (Pubitemid 32843253)
72. Yamane MA, Williams AC, Barry BW (1995) Effect of terpenes and oleic acid as skin penetratin enhancers toward 5-Fluorouracil as assessed with time; permeation partitioning and differential scanning calorimetry. Int J Pharm 116:237-251
73. Yamane MA, Williams AC, Barry BW (1995) Terpenes penetration enhancers in propylene glycol/water co-solvent system effectiveness and mechanism of action. J Pharm Pharmacol 47:978-989 (Pubitemid 26048166)
74. 2+ exchange activity of canine cardiac sarcolemmal vesicles. Biochem Biophys Acta 897:481-487
75. Deng S, May BH, Zhang AL, Lu C, Xue CC (2013) Topical herbal medicine combined with pharmacotherapy for psoriasis: a systematic review and meta-analysis. Arch Dermatol Res 305:179-189
76. Kage M, Tokudome Y, Hashimoto F (2013) Permeation of hyaluronan tetrasaccharides through hairless mouse skin: an in vitro and in vivo study. Arch Dermatol Res 305:69-77
77. Kataoka S, Hattori K, Date A, Tamura H (2013) Human keratinocyte caspase-14 expression is altered in human epidermal 3D models by dexamethasone and by natural products used in cosmetics. Arch Dermatol Res. doi:10.1007/s00403-013-1359-0